Distinguished Abstract
Meeting
Search Results for teamwork
Abstract Number: E47
SHM Converge 2022
Case Presentation: A 27-year-old Hispanic man with a history of hyperlipidemia and smoking (marijuana and tobacco) was initially seen by Urology for a right palpable testicular mass that enlarged over the past 2 months prior to presentation. Our patient denied a history of familial testicular cancer and a history of undescended testes. He reported no [...]
Abstract Number: E48
SHM Converge 2022
Case Presentation: A 79-year-old Caucasian male presented to the hospital with complaints of worsening generalized weakness, difficulty swallowing, and shortness of breath for about 3 weeks. His past medical history was significant for metastatic melanoma (metastasis to brain, lung). He received his first session of immunotherapy with Ipilimumab and Nivolumab one month before his presentation [...]
Abstract Number: E49
SHM Converge 2022
Case Presentation: A 68 year-old male with past medical history of alcohol use presented after a motor vehicle accident. Labs showed a hemoglobin (Hb) of 12.4 mmol/L and platelet (plt) count 235 x 10^9/L. He received four units of whole blood in the emergency department and underwent repair of left lower extremity fractures. He was [...]
Abstract Number: F10
SHM Converge 2022
Background: COVID-19 cases first emerged in China in December 2019. An air of fear and anxiety engulfed the globe as it rapidly spread across borders affecting the entire human race. Media outlets started reporting information containing rising death tolls and horrific visuals generating a global hysteria(1). Stress is a well-known trigger for acute coronary syndromes [...]
Abstract Number: F11
SHM Converge 2022
Background: Over two-thirds of workplace assaults in the United States occur in healthcare and social services settings. Patients/visitors are the most common source of workplace violence (WPV), called type II WPV. Nurses, clinicians working in the emergency room, behavioral and psychiatry wards are at high risk for type II WPV. National and international organizations recommend [...]
Abstract Number: F12
SHM Converge 2022
Background: Pulmonary embolism (PE) is the third most common vascular disease in the US, frequently underdiagnosed and potentially fatal condition where embolic material blocks one or more pulmonary arteries impairing blood flow. In this study, we aim to describe the prevalence, outcomes, and predictors of mortality of mechanical (MT) and surgical thrombectomy (ST). Methods: This [...]
Abstract Number: F13
SHM Converge 2022
Background: The use of metered-dose inhalers (MDIs) with spacers for delivering bronchodilator therapy is established as equivalent to the use of nebulizers (nebs) for symptom response.[1-3] Additional well-documented benefits to using MDIs in place of nebs include fewer systemic side effects, better long-term patient adherence to therapy, and, in the era of COVID-19, decreased use [...]
Abstract Number: F14
SHM Converge 2022
Background: Non-beneficial treatment can be defined as medical interventions that are ineffective in achieving a patient’s desired goals or subject patients to discomfort without significant clinical benefit. At times, critically-ill patients are declined Intensive Care Unit (ICU) admission due to perceived lack of benefit but continue to be medically managed on the general medical floor. [...]
Abstract Number: F15
SHM Converge 2022
Background: Constraints on resources require healthcare systems to implement alternative and innovative means for delivering care. The COVID-19 pandemic amplified this issue throughout the world, leading to shortages of ventilators, hospital beds, and healthcare personnel. We report the results of an Acute Care at Home (ACH) program’s response to COVID-19, providing in-home hospital-level care to [...]
Abstract Number: F16
SHM Converge 2022
Background: Treatment of complicated urinary tract infections (cUTI), including acute pyelonephritis (AP) due to multi-drug resistant (MDR) Gram-negative uropathogens (e.g., extended-spectrum ß-lactamase (ESBL)-producing and fluoroquinolone-resistant strains) is associated with poor outcomes and increase costs of care. In the setting of limited alternative oral options, patients with cUTI/AP are commonly hospitalized to receive intravenous (IV) antibiotic [...]